 | ATM-dependent phosphorylation of Rad50 mediates the DNA damage response, 2008 - 2009
Funded by: Cancer Council Queensland |
| Improved markers for prostate cancer detection, 2008 - 2008
Funded by: Australasian Urology Foundation |
| Molecular profiling for prostate cancer prognosis, 2008 - 2009
Funded by: Royal Brisbane & Women'S Hospital Foundation |
| Pre-clinical evaluation of snake venom proteins with therapeutic potential, 2008 - 2011
Funded by: Australian Research Council, University Of Queensland, Venomics Pty Limited |
| Role of obesity in impaired treatment response in chronic hepatitis C: mechanisms and therapeutic strategies, 2008 - 2010
Funded by: National Health and Medical Research Council |
| Targeting glioma stem cells as a potential therapy for glioblastoma multiforme, 2008 - 2009
Funded by: Cancer Bequest Fund |
| Cellular Activation and Apoptosis in Response to Foreign Cytoplasmic DNA, 2007 - 2009
Funded by: National Health and Medical Research Council |
| Hepatocyte replicative arrest, hepatic progenitor cells and the ductular reaction in hepatic fibrogenesis, 2007 - 2009
Funded by: National Health and Medical Research Council |
| Senataxin, a novel protein involved in the DNA damage response, 2007 - 2009
Funded by: National Health and Medical Research Council |
| Identification of functionally important autophosphorylation site(s) on ataxia telangiectasia and Rad 3 related (ATR) protein kinase, 2006 - 2008
Funded by: Australian Research Council |
| Indirect Calorimetry to monitor changes in energy requirements of adult burn patients, 2006 - 2008
Funded by: The University of Queensland, Royal Brisbane & Women'S Hospital Foundation |
| Mechanism of activation of ATM by DNA double strand breaks and other stimuli, 2006 - 2008
Funded by: National Health and Medical Research Council |
| Metabolic complications of liver transplantation, 2006 - 2006
Funded by: Princess Alexandra Hospital Auxiliary |
| Metabolism and exercise post-burn injury, 2006 - 2008
Funded by: The University of Queensland |
| Prostate Cancer markers of progression and metastasis - Bruce Pearson Fellowship 2006, 2006 - 2006
Funded by: Australasian Urology Foundation |
| Role of regulatory T cells in outcome of paediatric liver transplantation, 2006 - 2007
Funded by: Sasakawa Memorial Fund |
| The Role Of Hepatic Progenitor Cells And A Ductular Reaction In Disease Progression In Non-Alcoholic Fatty Liver Disease, 2006 - 2009
Funded by: Princess Alexandra Hospital Auxiliary |
| The use of rapamycin to slow scarring of the liver, 2006 - 2007
Funded by: Royal Children's Hospital |
| A new strategy for successful liver cell transplantation for children with liver disease., 2005 - 2005
Funded by: Royal Children's Hospital |
| Australasian Clinical Trials Network in Nephrology (CTNN), 2005 - 2011
Funded by: Australian Kidney Foundation |
| Australasian Kidney Trials (AKT) Network, 2005 - 2010
Funded by: National Health And Medical Research Council |
| Evaluation of two doses of SR31747A (75mg and 125mg) in non-metastatic androgen-independant prostate cancer. Randomized, double-blind, pacebo controlled Phase II Study. (Odyssey Study), 2005 - 2007
Funded by: Sanofi - Synthelabo Australia Pty Ltd |
| Functional role of Aprataxin: mutated in ataxia with oculomotor apraxia, 2005 - 2007
Funded by: National Health and Medical Research Council |
| Functional significance of ATM-dependent phosphorylation of Mre11, 2005 - 2007
Funded by: National Health and Medical Research Council |
| Multiple Molecular Markers for Prostate Cancer Diagnosis from Enriched Cells from Ejaculate, 2005 - 2007
Funded by: Queensland Cancer Fund |
| Page: | 1 2 3 4 5 6 7 8 9 
|
| Select all records |
| |
» Contacts
